Juan Mario Solis Paredes

Dr. Juan Mario Solis Paredes

Reproductive and Perinatal Health Research, Instituto Nacional de Perinatología, Mexico City, Ciudad de México, Mexico
orcid
Medical Sciences Researcher

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
BSBlanca Vianey Suarez-Rico
Blanca Vianey Suarez-Rico
GEGuadalupe Estrada-Gutierrez
Guadalupe Estrada-Gutierrez
MSMaribel Sánchez-Martínez
Maribel Sánchez-Martínez
OPOtilia Perichart
Otilia Perichart
CRCarolina Rodríguez-Hernández
Carolina Rodríguez-Hernández
EREnrique Reyes-Muñoz
Enrique Reyes-Muñoz
The COVID-19 lockdown represents a new challenge for mental health researchers and clinical practitioners. This cross-sectional study aimed to investigate the prevalence of depression, anxiety, and perceived stress in postpartum Mexican women. The study included 293, 4–12-week postpartum women over the age of 18. The Edinburgh Postpartum Depression Scale (EPDS), Trait-State Trait Anxiety Inventory (T-STAI), and Ten Perceived Stress Scale (PSS-10), which are all questionnaires validated for the Mexican population, were applied using a web-based online survey. Prevalence and 95% confidence intervals (CIs) were calculated. The mean ± standard deviation (SD) of the maternal age was 29.9 ± 6.3 years; the EPDS score: 11 ± 6, T-STAI score: 41.7 ± 12.3, and PSS-10 score: 17.1 ± 7. The prevalence (95% CI) of the postpartum depression symptoms was 39.2% (34–45%), trait anxiety symptoms were found among 46.1% (32–43%) of the participants, and moderate and high perceived stress were in 58% (52–64) and 10.9% (7.8–15) of the participants, respectively. The prevalence of depressive symptoms, generalized anxiety, and perceived stress was higher among postpartum Mexican women during the COVID-19 outbreak than before the lockdown. Our findings highlight the importance of monitoring perinatal mental health during pandemics and the need to design effective psychologic interventions for these patients.

Verified
Journal Article
Open access
PDF file
Johnatan TorresJohnatan Torres
Johnatan Torres
IMIrma Eloisa Monroy Muñoz
Irma Eloisa Monroy Muñoz
JPJavier Pérez-Durán
Javier Pérez-Durán
Juan Mario Solis ParedesJuan Mario Solis Paredes
Juan Mario Solis Paredes
Zaira Alexi Camacho-Martinez Camacho-MartinezZaira Alexi Camacho-Martinez Camacho-Martinez
Zaira Alexi Camacho-Martinez Camacho-Martinez
EREnrique Reyes-Muñoz
Enrique Reyes-Muñoz
Gestational diabetes (GD) is a metabolic disorder characterized by glucose intolerance during pregnancy, significantly impacting maternal and fetal health. Its global prevalence is approximately 14%, with risk factors including obesity, family history of diabetes, advanced maternal age, and ethnicity, which are linked to cellular and molecular disruptions in glucose regulation and insulin resistance. GD is associated with short- and long-term complications for both the mother and the newborn. For mothers, GD increases the risk of developing type 2 diabetes, cardiovascular diseases, and metabolic syndrome. In the offspring, exposure to GD in utero predisposes them to obesity, glucose intolerance, and metabolic disorders later in life. This review aims to elucidate the complex cellular and molecular mechanisms underlying GD to inform the development of effective therapeutic strategies. A systematic review was conducted using medical subject headings (MeSH) terms related to GD’s cellular and molecular pathophysiology. Inclusion criteria encompassed original studies, systematic reviews, and meta-analyses focusing on GD’s impact on maternal and fetal health, adhering to PRISMA guidelines. Data extraction captured study characteristics, maternal and fetal outcomes, key findings, and conclusions. GD disrupts insulin signaling pathways, leading to impaired glucose uptake and insulin resistance. Mitochondrial dysfunction reduces ATP production and increases reactive oxygen species, exacerbating oxidative stress. Hormonal influences, chronic inflammation, and dysregulation of the mammalian target of rapamycin (mTOR) pathway further impair insulin signaling. Gut microbiota alterations, gene expression, and epigenetic modifications play significant roles in GD. Ferroptosis and placental dysfunction primarily contribute to intrauterine growth restriction. Conversely, fetal macrosomia arises from maternal hyperglycemia and subsequent fetal hyperinsulinemia, resulting in excessive fetal growth. The chronic inflammatory state and oxidative stress associated with GD exacerbate these complications, creating a hostile intrauterine environment. GD’s complex pathophysiology involves multiple disruptions in insulin signaling, mitochondrial function, inflammation, and oxidative stress. Effective management requires early detection, preventive strategies, and international collaboration to standardize care and improve outcomes for mothers and babies.

22 April 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JCJ. Arturo Cardona-Pérez
J. Arturo Cardona-Pérez
IVIsabel Villegas-Mota
Isabel Villegas-Mota
AHA. Cecilia Helguera-Repetto
A. Cecilia Helguera-Repetto
SASandra Acevedo-Gallegos
Sandra Acevedo-Gallegos
MRMario Rodríguez-Bosch
Mario Rodríguez-Bosch
CIClaudine Irles
Claudine Irles
The perinatal consequences of SARS-CoV-2 infection are still largely unknown. This study aimed to describe the features and outcomes of pregnant women with or without SARS-CoV-2 infection after the universal screening was established in a large tertiary care center admitting only obstetric related conditions without severe COVID-19 in Mexico City. This retrospective case-control study integrates data between April 22 and May 25, 2020, during active community transmission in Mexico, with one of the highest COVID-19 test positivity percentages worldwide. Only pregnant women and neonates with a SARS-CoV-2 result by quantitative RT-PCR were included in this study. Among 240 pregnant women, the prevalence of COVID-19 was 29% (95% CI, 24% to 35%); 86% of the patients were asymptomatic (95% CI, 76%-92%), nine women presented mild symptoms, and one patient moderate disease. No pregnancy baseline features or risk factors associated with severity of infection, including maternal age > 35 years, Body Mass Index >30 kg/m2, and pre-existing diseases, differed between positive and negative women. The median gestational age at admission for both groups was 38 weeks. All women were discharged at home without complications, and no maternal death was reported. The proportion of preeclampsia was higher in positive women than negative women (18%, 95% CI, 10%-29% vs. 9%, 95% CI, 5%-14%, P<0.05). No differences were found for other perinatal outcomes. SARS-CoV-2 test result was positive for nine infants of positive mothers detected within 24h of birth. An increased number of infected neonates were admitted to the NICU, compared to negative neonates (44% vs. 22%, P<0.05) and had a longer length of hospitalization (2 [2–18] days vs. 2 [2–3] days, P<0.001); these are potential proxies for illness severity. This report highlights the importance of COVID-19 detection at delivery in pregnant women living in high transmission areas.

17 December 2021 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
JTJ. Torres‐Torres
J. Torres‐Torres
Raigam Jafet Martinez Martinez-PortillaRaigam Jafet Martinez Martinez-Portilla
Raigam Jafet Martinez Martinez-Portilla
SES. Espino‐Y‐Sosa
S. Espino‐Y‐Sosa
GEG. Estrada‐Gutierrez
G. Estrada‐Gutierrez
Juan Mario Solis ParedesJuan Mario Solis Paredes
Juan Mario Solis Paredes
LPLiona C. Poon
Liona C. Poon
Objective: Mortality in pregnancy due to coronavirus disease 2019 (COVID‐19) is a current health priority in developing countries. Identification of clinical and sociodemographic risk factors related to mortality in pregnant women with COVID‐19 could guide public policy and encourage such women to accept vaccination. We aimed to evaluate the association of comorbidities and socioeconomic determinants with COVID‐19‐related mortality and severe disease in pregnant women in Mexico.Methods: This is an ongoing nationwide prospective cohort study that includes all pregnant women with a positive reverse‐transcription quantitative polymerase chain reaction result for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) from the Mexican National Registry of Coronavirus. The primary outcome was maternal death due to COVID‐19. The association of comorbidities and socioeconomic characteristics with maternal death was explored using a log‐binomial regression model adjusted for possible confounders.Results: There were 176 (1.35%) maternal deaths due to COVID‐19 among 13 062 consecutive SARS‐CoV‐2‐positive pregnant women. Maternal age, as a continuous (adjusted relative risk (aRR), 1.08 (95% CI, 1.05–1.10)) or categorical variable, was associated with maternal death due to COVID‐19; women aged 35–39 years (aRR, 3.16 (95% CI, 2.34–4.26)) or 40 years or older (aRR, 4.07 (95% CI, 2.65–6.25)) had a higher risk for mortality, as compared with those aged < 35 years. Other clinical risk factors associated with maternal mortality were pre‐existing diabetes (aRR, 2.66 (95% CI, 1.65–4.27)), chronic hypertension (aRR, 1.75 (95% CI, 1.02–3.00)) and obesity (aRR, 2.15 (95% CI, 1.46–3.17)). Very high social vulnerability (aRR, 1.88 (95% CI, 1.26–2.80)) and high social vulnerability (aRR, 1.49 (95% CI, 1.04–2.13)) were associated with an increased risk of maternal mortality, while very low social vulnerability was associated with a reduced risk (aRR, 0.47 (95% CI, 0.30–0.73)). Being poor or extremely poor were also risk factors for maternal mortality (aRR, 1.53 (95% CI, 1.09–2.15) and aRR, 1.83 (95% CI, 1.32–2.53), respectively).Conclusion: This study, which comprises the largest prospective consecutive cohort of pregnant women with COVID‐19 to date, has confirmed that advanced maternal age, pre‐existing diabetes, chronic hypertension, obesity, high social vulnerability and low socioeconomic status are risk factors for COVID‐19‐related maternal mortality. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
EVEDGAR RICARDO VAZQUEZ-MARTINEZ
EDGAR RICARDO VAZQUEZ-MARTINEZ
CBClaudia Bello-Alvarez
Claudia Bello-Alvarez
AHAna Lorena Hermenegildo-Molina
Ana Lorena Hermenegildo-Molina
Juan Mario Solis ParedesJuan Mario Solis Paredes
Juan Mario Solis Paredes
Sandra Parra HernandezSandra Parra Hernandez
Sandra Parra Hernandez
ICIgnacio Camacho-Arroyo
Ignacio Camacho-Arroyo
Endometriosis is one of the most frequent gynecological diseases in reproductive age women, but its etiology is not completely understood. Endometriosis is characterized by progesterone resistance, which has been explained in part by a decrease in the expression of the intracellular progesterone receptor in the ectopic endometrium. Progesterone action is also mediated by nongenomic mechanisms via membrane progesterone receptors (mPRs) that belong to the class II members of the progesterone and adipoQ receptor (PAQR) family. The aim of the present study was to evaluate the expression at mRNA and protein levels of mPR members in the eutopic and ectopic endometrium of women with endometriosis. Total RNA and total protein were isolated from control endometrium (17 samples), eutopic endometrium (17 samples), and ectopic endometrium (9 samples). The expression of PAQR7 (mPRα), PAQR8 (mPRβ), and PAQR6 (mPRδ) at mRNA and protein levels was evaluated by RT‐qPCR and Western blot, whereas PAQR5 (mPRγ) gene expression was evaluated by RT‐qPCR. Statistical analysis between comparable groups was performed using one‐way ANOVA followed by Tukey’s multiple comparisons test with a confidence interval of 95 %. The analysis of gene expression showed that PAQR7 and PAQR5 expression was lower in both eutopic and ectopic endometrium as compared to the endometrium of women without endometriosis, whereas the expression of PAQR8 and PAQR6 was only reduced in eutopic endometrium. Furthermore, mPRα and mPRβ protein content was decreased in the ectopic endometrium of women with endometriosis. Our results demonstrate a decrease in the expression and protein content of mPRs in eutopic and ectopic endometrium of patients with endometriosis, which could contribute to the progesterone resistance observed in patients with this disease.

23 September 2021 in Viruses
Verified
Journal Article
Open access
PDF file
Salvador Espino y SosaSalvador Espino y Sosa
Salvador Espino y Sosa
Raigam Jafet Martinez Martinez-PortillaRaigam Jafet Martinez Martinez-Portilla
Raigam Jafet Martinez Martinez-Portilla
Johnatan TorresJohnatan Torres
Johnatan Torres
Juan Mario Solis ParedesJuan Mario Solis Paredes
Juan Mario Solis Paredes
GEGuadalupe Estrada-Gutierrez
Guadalupe Estrada-Gutierrez
LPLiona C. Poon
Liona C. Poon
Background: In healthy pregnancies, components of the Renin-Angiotensin system (RAS) are present in the placental villi and contribute to invasion, migration, and angiogenesis. At the same time, soluble fms-like tyrosine kinase 1 (sFlt-1) production is induced after binding of ANG-II to its receptor (AT-1R) in response to hypoxia. As RAS plays an essential role in the pathogenesis of COVID-19, we hypothesized that angiogenic marker (sFlt-1) and RAS components (ANG-II and ACE-2) may be related to adverse outcomes in pregnant women with COVID-19; Methods: Prospective cohort study. Primary outcome was severe pneumonia. Secondary outcomes were ICU admission, intubation, sepsis, and death. Spearman’s Rho test was used to analyze the correlation between sFlt-1 and ANG-II levels. The sFlt-1/ANG-II ratio was determined and the association with each adverse outcome was explored by logistic regression analysis and the prediction was assessed using receiver-operating-curve (ROC); Results: Among 80 pregnant women with COVID-19, the sFlt-1/ANG-II ratio was associated with an increased probability of severe pneumonia (odds ratio [OR]: 1.31; p = 0.003), ICU admission (OR: 1.05; p = 0.007); intubation (OR: 1.09; p = 0.008); sepsis (OR: 1.04; p = 0.008); and death (OR: 1.04; p = 0.018); Conclusion: sFlt-1/ANG-II ratio is a good predictor of adverse events such as pneumonia, ICU admission, intubation, sepsis, and death in pregnant women with COVID-19.